TY  - JOUR
AU  - Carrato, Alfredo
AU  - Abad, Albert
AU  - Massuti, Bartomeu
AU  - Grávalos, Cristina
AU  - Escudero, Pilar
AU  - Longo-Muñoz, Federico
AU  - Manzano, José-Luis
AU  - Gómez, Auxiliadora
AU  - Safont, María José
AU  - Gallego, Javier
AU  - García-Paredes, Beatriz
AU  - Pericay, Carles
AU  - Dueñas, Rosario
AU  - Rivera, Fernando
AU  - Losa, Ferrán
AU  - Valladares-Ayerbes, Manuel
AU  - González, Encarnación
AU  - Aranda, Enrique
AU  - Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
PY  - 2017
DO  - 10.1016/j.ejca.2017.04.024
UR  - http://hdl.handle.net/10668/11325
T2  - European journal of cancer (Oxford, England : 1990)
AB  - In first-line wild-type (WT)-Kirsten rat sarcoma viral oncogene homologue (KRAS) metastatic colorectal cancer (mCRC), panitumumab (Pmab) improves outcomes when added to FOLFOX [folinic acid, 5-fluorouracil, and oxaliplatin] or FOLFIRI [folinic acid,...
LA  - en
KW  - FOLFIRI
KW  - FOLFOX
KW  - First-line
KW  - Liver-limited disease
KW  - Metastatic colorectal cancer
KW  - Panitumumab
KW  - Resection
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antibodies, Monoclonal
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Camptothecin
KW  - Colorectal Neoplasms
KW  - Female
KW  - Fluorouracil
KW  - Humans
KW  - Leucovorin
KW  - Liver Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Organoplatinum Compounds
KW  - Panitumumab
KW  - Spain
KW  - Survival Analysis
TI  - First-line panitumumab plus FOLFOX4 or FOLFIRI in colorectal cancer with multiple or unresectable liver metastases: A randomised, phase II trial (PLANET-TTD).
TY  - research article
VL  - 81
ER  -